Profile

iCLASS is a revolutionary TechBIO company merging multi-proteomics-centered data generation with next-generation machine learning. By unlocking biologically relevant, highly translatable insights, iCLASS maximizes R&D efficiency and drives zero-dollar loss per dollar invested. The company is establishing a new vertical in drug discovery with a robust portfolio of early-stage assets, including programs targeting previously “undruggable” mechanisms. iCLASS is committed to innovation and is reshaping the boundaries of what’s possible in therapeutic development.

iCLASS Discovery logo
iclasscube.com

Contact

Event details

Date: November 3 - 5, 2025

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

22 in total
  • 20/20 OptimEyes Technologies Inc.
    20/20 OptimEyes Technologies has developed a mucoadhesive drug delivery platform technology that allows for…
  • BioBackers
    BioBackers is a nascent investor intelligence platform for therapeutics companies raising capital. The platform…
  • BioScript Solutions
    BioScript Solutions is a Canadian healthcare company committed to simplifying access to specialty care. It…
  • Bough Biosciences
    Bough Biosciences is a pre-seed stage biotech focused on the development of a therapy for treatment resistant…
  • HDAX Therapeutics
    HDAX Therapeutics, a biotechnology company pioneering a novel approach to target…
  • iCLASS Discovery
    iCLASS is a revolutionary TechBIO company merging multi-proteomics-centered data generation with next-generation…
  • Intrepid Labs Inc.
    Intrepid Labs revolutionizes drug formulation with Valiant™, an AI-driven robotic lab that explores…
  • JN Nova Pharma Inc.
    JN Nova Pharma is Canadian biotech company which has worked with National Research Council of Canada…
  • Noa Therapeutics
    Noa Therapeutics is pioneering a novel biased signal approach to AhR…
  • Pattern Pharma Inc.
    Pattern’s patented PPI-100 activates innate immunity against cancers…
  • PlantForm Corporation
    PlantForm Corporation is a biopharmaceutical company focused on the rapid development and production of specialty…
  • ProteinQure Inc.
    ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead…
  • Q&C Services
    Q&C Services is Canada’s largest independent full-service consultant and importer for pharmaceutical, natural…
  • QurCan Therapeutics
    QurCan Therapeutics is advancing the next wave of genetic medicines for CNS…
  • Rhythm Biotherapeutics Inc.
    Rhythm Biotherapeutics develops first-in-class, heart-derived exosome therapeutics to prevent atrial fibrillation…
  • Singularity Pharma
    Singularity Pharma is a drug discovery business developing novel therapeutics for…
  • Specific Biologics
    Specific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class…
  • Spiderwort Biotechnologies
    Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number…
  • TheraVac Biologics
    TheraVac Biologics is a late-stage preclinical company developing innovative immunotherapies for…
  • Transpharmation
    Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide…
  • Virano Therapeutics
    Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the…
  • YYZ Pharmatech Inc.
    YYZ Pharmatech Inc. (“YYZ”) is a deep tech company endeavoring to profoundly progress new medicine…